The role of anti-Mullerian hormone in the differentiation, development, and functioning of the reproductive system

The integral analysis of the available information concerning the role of anti-Mullerian hormone (AMH) in the differentiation, development, and functioning of the reproductive system allows to make the following conclusion. The germ cells predetermine AMH biosynthesis from beginning to end of functioning of the reproductive system. The onset of germ cell meiosis restricts biosyhthesis of anti-Mullerian hormone that is maintained at a constant level throughout the rest of the period of reproductive maturity. AMH biosynthesis becomes arrested with the decrease of gametogenesis.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  2011-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.14341/PROBL201157639-44
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypogonadism in females with Prader-Willi syndrome from infancy to adulthood: variable combinations of a primary gonadal defect and hypothalamic dysfunction.

  2010cited by this paper
• Müllerian inhibiting substance contributes to sex-linked biases in the brain and behavior

  2009cited by this paper
• Anti muellerian hormone serum levels in women with endometriosis: A case–control study

  2009cited by this paper
• Primary testicular dysfunction is a major contributor to abnormal pubertal development in males with Prader-Willi syndrome.

  2009cited by this paper
• Anti-Mullerian hormone (AMH): what do we still need to know?

  2009cited by this paper
• The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count.

  2009cited by this paper
• Lack of androgen receptor expression in Sertoli cells accounts for the absence of anti-Mullerian hormone repression during early human testis development.

  2009cited by this paper
• Seminal anti-Müllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism.

  2008cited by this paper
• Anti-Müllerian hormone and ovarian dysfunction.

  2008cited by this paper
• Anti-Mullerian-hormone-dependent regulation of the brain serine-protease inhibitor neuroserpin

  2008cited by this paper
• Physiological androgen insensitivity of the fetal, neonatal, and early infantile testis is explained by the ontogeny of the androgen receptor expression in Sertoli cells.

  2008cited by this paper
• The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome.

  2008cited by this paper
• The Müllerian Duct: Recent Insights into Its Development and Regression

  2007cited by this paper
• Persistent mullerian duct syndrome and transverse testicular ectopia: embryology, presentation, and management.

  2007cited by this paper
• Seminal plasma anti-Müllerian hormone level correlates with semen parameters but does not predict success of testicular sperm extraction (TESE).

  2007cited by this paper
• Testicular adrenal rest tumors and Leydig and Sertoli cell function in boys with classical congenital adrenal hyperplasia.

  2007cited by this paper
• Testicular anti-Müllerian hormone: history, genetics, regulation and clinical applications.

  2006cited by this paper
• Anti-mullerian hormone: clinical relevance in assisted reproductive therapy.

  2006cited by this paper
• Anti‐Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?

  2006cited by this paper
• AMH and AMH receptor defects in persistent Müllerian duct syndrome.

  2005cited by this paper
• Testicular anti-mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism.

  2005cited by this paper
• Anti-Müllerian hormone in disorders of sex determination and differentiation.

  2005cited by this paper
• Persistent Mullerian duct syndrome with bilateral abdominal testis: surgical approach and review of the literature.

  2005cited by this paper
• Mutations of the anti-mullerian hormone gene in patients with persistent mullerian duct syndrome: biosynthesis, secretion, and processing of the abnormal proteins and analysis using a three-dimensional model.

  2004cited by this paper
• Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.

  2004cited by this paper
• Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood.

  2003cited by this paper
• The role of Müllerian inhibiting substance in the evaluation of phenotypic female patients with mild degrees of virilization.

  2003cited by this paper
• Components of the anti-Müllerian hormone signaling pathway in gonads.

  2003cited by this paper
• Hypogonadotropic hypogonadism as a model of post-natal testicular anti-Müllerian hormone secretion in humans.

  2003cited by this paper
• AMH signaling: from receptor to target gene.

  2003cited by this paper
• Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.

  2001cited by this paper
• Anti-Müllerian hormone and its receptors.

  2001cited by this paper
• Evaluation of the Tubular and Interstitial Functions of the Testis in 46,XY Patients with Ambiguous Genitalia

  2000cited by this paper
• Antimüllerian hormone in patients with hypogonadotropic hypogonadism.

  1999cited by this paper
• Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement.

  1999cited by this paper
• Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads.

  1997cited by this paper
• Mullerian inhibiting substance in humans: normal levels from infancy to adulthood.

  1996cited by this paper
• Paediatric applications of anti-müllerian hormone research. 1992 Andrea Prader Lecture.

  1995cited by this paper
• Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone.

  1994cited by this paper
• Mapping of the gene for anti-müllerian hormone to the short arm of human chromosome 19.

  1987cited by this paper
• Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells.

  1986cited by this paper
• Cloning and expression of cDNA for anti-müllerian hormone.

  1986cited by this paper
• Purification of testicular anti-Müllerian hormone allowing direct visualization of the pure glycoprotein and determination of yield and purification factor.

  1984cited by this paper
• Familial persistent müllerian duct syndrome.

  1984cited by this paper

• Study of anti-Müllerian hormone in predicting embryo productivity of donor cows

  2025cites this paper
• Expression of the anti-Müllerian hormone receptor (AMHR2) in the endometrium of patients with uterine anomalies

  2021cites this paper